Fatty acids induce amylin expression and secretion by pancreatic β-cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 298, Issue 1, 2010, Pages

  Qi, Dongfei ^a   Cai, Kun ^a   Wang, Oumei ^a   Li, Zongmeng ^a   Chen, Juan ^a   Deng, Bo ^a   Qian, Lihua ^a   Le, Yingying ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Gene expression; High lipid diet; Insulin; Islet amyloid polypeptide; Pancreas; Signal transduction

Indexed keywords

AMYLIN; CALCIUM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOHEXIMIDE; EGTAZIC ACID; HOMEODOMAIN PROTEIN; INSULIN; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FEMALE; GENE ACTIVATION; GENETIC TRANSCRIPTION; HORMONE RELEASE; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; UPREGULATION;

AMYLOID; ANIMALS; BLOOD GLUCOSE; CALCIUM; CELLS, CULTURED; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED C57BL; OLEIC ACID; PALMITATES; PROTEIN KINASE C; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 73649102726     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00242.2009     Document Type: Article

References (50)

1. Alcazar O, Qiu-yue Z, Gine E, Tamarit-Rodriguez J. Stimulation of islet protein kinase C translocation by palmitate requires metabolism of the fatty acid. Diabetes 46: 1153-1158, 1997.
2. Bollheimer LC, Kemptner DM, Kagerbauer SM, Kestler TM, Wrede CE, Buettner R. Intracellular depletion of insulin: a comparative study with palmitate, oleate and elaidate in INS-1 cells. Eur J Endocrinol 148:481-486, 2003.
3. Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101: 1094-1101, 1998.
4. Busch AK, Cordery D, Denyer GS, Biden TJ. Expression profiling of palmitate- and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic beta-cell function. Diabetes 51: 977-987, 2002.
5. Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752-756, 1990.
6. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628-8632, 1987.
7. Duplus E, Glorian M, Forest C. Fatty acid regulation of gene transcription. J Biol Chem 275: 30749-30752, 2000.
8. Enoki S, Mitsukawa T, Takemura J, Nakazato M, Aburaya J, Toshimori H, Matsukara S. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 15: 97-102, 1992.
9. Fehmann HC, Weber V, Goke R, Goke B, Arnold R. Cosecretion of amylin and insulin from isolated rat pancreas. FEBS Lett 262: 279-281, 1990.
10. Gasa R, Gomis R, Casamitjana R, Novials A. High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets. Pancreas 22: 307-310, 2001.
11. Gasa R, Gomis R, Casamitjana R, Rivera F, Novials A. Glucose regulation of islet amyloid polypeptide gene expression in rat pancreatic islets. Am J Physiol Endocrinol Metab 272: E543-E549, 1997.
12. Gasa R, Gomis R, Casamitjana R, Novials A. Signals related to glucose metabolism regulate islet amyloid polypeptide (IAPP) gene expression in human pancreatic islets. Regul Pept 68: 99-104, 1997.
13. Golay A, Swislocki AL, Chen YD, Jaspan JB, Reaven GM. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab 63: 481-484, 1986.
14. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72: 96-107, 1991.
15. Haber EP, Ximenes HM, Procópio J, Carvalho CR, Curi R, Carpinelli AR. Pleiotropic effects of fatty acids on pancreatic beta-cells. J Cell Physiol 194: 1-12, 2003.
16. Hong Chung B, Hennig B, Cho BHS, Darnell BE. Effect of the fat composition of a single meal on the composition and cytotoxic potencies of lipolytically-releasable free fatty acids in postprandial plasma. Atherosclerosis 141: 321-332, 1998.
17. Hoppener JW, Oosterwijk C, Nieuwenhuis MG, Posthuma G, Thijssen JH, Vroom TM, Ahren B, Lips CJ. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 42: 427-434, 1999.
18. Huang Cj, Haataja L, Gurlo T, Butler AE, Wu X, Soeller WC, Butler PC. Induction of endoplasmic reticulum stress-induced -cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide. Am J Physiol Endocrinol Metab 293: E1656-E1662, 2007.
19. Huang Cj, Lin CY, Haataja L, Gurlo T, Butler AE, Rizza RA, Butler PC. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated (beta)-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 56: 2016-2027, 2007.
20. Huang HJ, Young AA, Koda JE, Tulp OL, Johnson MJ, Cooper GJ. Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats. Hypertension 19: I101-I109, 1992.
21. Hull RL, Andrikopoulos S, Verchere CB, Vidal J, Wang F, Cnop M, Prigeon RL, Kahn SE. Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52: 372-379, 2003.
22. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr, Porte D Jr. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39: 634-638, 1990.
23. Leighton B, Cooper GJ. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632-635, 1988.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408, 2001.
25. Lukinius A, Wilander E, Westermark GT, Engstrom U, Westermark P. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32: 240-244, 1989.
26. Lutz TA. Amylinergic control of food intake. Physiol Behav 89: 465-471, 2006.
27. Ma Z, Westermark GT. Effects of free fatty acid on polymerization of islet amyloid polypeptide (IAPP) in vitro and on amyloid fibril formation in cultivated isolated islets of transgenic mice overexpressing human IAPP. Mol Med 8: 863-868, 2002.
28. Macfarlane WM, Campbell SC, Elrick LJ, Oates V, Bermano G, Lindley KJ, Aynsley-Green A, Dunne MJ, James RF, Docherty K. Glucose regulates islet amyloid polypeptide gene transcription in a PDX1-and calcium-dependent manner. J Biol Chem 275: 15330-15335, 2000.
29. 2+. Diabetes 49: 418-423, 2000.
30. Marzban L, Park K, Verchere CB. Islet amyloid polypeptide and type 2 diabetes. Exp Gerontol 38: 347-351, 2003.
31. Matveyenko AV, Butler PC. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. ILAR J 47: 225-233, 2006.
32. McDaniel ML, Colca JR, Kotagal N, Lacy PE. A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. Methods Enzymol 98: 182-200, 1983.
33. Mott DM, Stone K, Gessel MC, Bunt JC, Bogardus C. Palmitate action to inhibit glycogen synthase and stimulate protein phosphatase 2A increases with risk factors for type 2 diabetes. Am J Physiol Endocrinol Metab 294: E444-E450, 2008.
34. Mulder H, Martensson H, Sundler F, Ahren B. Differential changes in islet amyloid polypeptide (amylin) and insulin mRNA expression after high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 49: 1518-1522, 2000.
35. Novials A, Sarri Y, Casamitjana R, Rivera F, Gomis R. Regulation of islet amyloid polypeptide in human pancreatic islets. Diabetes 42: 1514-1519, 1993.
36. Ohsawa H, Kanatsuka A, Yamaguchi T, Makino H, Yoshida S. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem Biophys Res Commun 160: 961-967, 1989.
37. Poitout V, Hagman D, Stein R, Artner I, Robertson RP, Harmon JS. Regulation of the insulin gene by glucose and fatty acids. J Nutr 136: 873-876, 2006.
38. Reinehr T, de SG, Niklowitz P, Roth CL. Amylin and its relation to insulin and lipids in obese children before and after weight loss. Obesity (Silver Spring) 15: 2006-2011, 2007.
39. 2+-signaling in pancreatic beta-cells. Mol Cell Endocrinol 212: 1-9, 2003.
40. Richieri GV, Kleinfeld AM. Unbound free fatty acid levels in human serum. J Lipid Res 36: 229-240, 1995.
41. Roche E, Buteau J, Aniento I, Reig JA, Soria B, Prentki M. Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. Diabetes 48: 2007-2014, 1999.
42. Soeller WC, Janson J, Hart SE, Parker JC, Carty MD, Stevenson RW, Kreutter DK, Butler PC. Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes 47: 743-750, 1998.
43. Sowa R, Sanke T, Hirayama J, Tabata H, Furuta H, Nishimura S, Nanjo K. Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 33: 118-120, 1990.
44. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD, McGarry JD. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100: 398-403, 1997.
45. Wang O, Cai K, Pang S, Wang T, Qi D, Zhu Q, Ni Z, Le Y. Mechanisms of glucose-induced expression of pancreatic-derived factor in pancreatic (beta)-cells. Endocrinology 149: 672-680, 2008.
46. Warnotte C, Gilon P, Nenquin M, Henquin JC. Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells. Diabetes 43: 703-711, 1994.
47. Westermark GT, Gebre-Medhin S, Steiner DF, Westermark P. Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol Med 6: 998-1007, 2000.
48. Westermark GT, Leckstrom A, Ma Z, Westermark P. Increased release of IAPP in response to long-term high fat intake in mice. Horm Metab Res 30: 256-258, 1998.
49. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127: 414-417, 1987.
50. Young AA, Jodka C, Pittner R, Parkes D, Gedulin BR. Dose-response for inhibition by amylin of cholecystokinin-stimulated secretion of amylase and lipase in rats. Regul Pept 130: 19-26, 2005.